CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262540421
- Phone
- 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- D Other Notice of Sales of Unregistered Securities
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 59,477 shares (grant or award)
- 4 Grant or award Director acquired 476 shares (grant or award)
- 4 Grant or award President and CEO acquired 20,000 shares (grant or award)
- 8-K Event Agreement ended · Other events
- 8-K Event Material agreement
- 8-K Event Results of operations
- 424B5 Offering Prospectus
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Restatement
- 8-K Event Other events
- 4 Option exercise President and CEO acquired 52,755 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 16 · 315 filings